<p>在今天发布的一份报告中，美国银行证券的安娜·利祖尔重申了对金佰利的买入评级，目标价为 120.00 美元。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>安娜·利祖尔给予买入评级是基于与金佰利拟收购 Kenvue 相关的一系列因素，以及该股票近期的回调。她认为金佰利是 Kenvue 资产的战略收购者，强调这些类别是互补的，并且收购价格和 EBITDA 倍数相对于 Kenvue 在与泰诺相关的压力之前的交易情况看起来很有吸引力。</p>
<p>她还强调了合并公司规模、预计收入和 EBITDA 基础以及计划中的成本和收入协同效应所带来的巨大价值创造潜力，特别是在 2026 年初经历困难后，如果行业估值倍数恢复。此外，她指出 Kenvue 的一些高增长、高利润品牌——特别是在自我护理领域——可能会随着时间的推移增强金佰利的投资组合，而对泰诺的法律风险的认知似乎正在减轻，这支持了她不变的 120 美元目标价和买入立场。</p>
<p>利祖尔覆盖消费防御行业，关注如 Clorox、金佰利和 Coty 等股票。根据 TipRanks 的数据，利祖尔推荐股票的平均回报为-2.5%，成功率为 38.79%。</p>
<p>在 4 月 29 日发布的另一份报告中，RBC 资本也重申了对该股票的买入评级，目标价为 162.00 美元。</p>

<p>来自美国银行证券的 Anna Lizzul 重申了对金佰利的买入评级，目标价为 120 美元。该评级得益于对 Kenvue 的战略收购，预计将通过协同效应创造价值，并增强金佰利的产品组合。Lizzul 指出了具有吸引力的购买价格和收入增长的潜力，尤其是在关于泰诺的法律问题缓解的情况下。RBC 资本也维持了买入评级，目标价上调至 162 美元</p>

<p>In a report released today, Anna Lizzul from Bank of America Securities reiterated a Buy rating on Kimberly Clark, with a price target of $120.00.</p>
<div class="lb-trans"><p>在今天发布的一份报告中，美国银行证券的安娜·利祖尔重申了对金佰利的买入评级，目标价为 120.00 美元。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>Anna Lizzul has given his Buy rating due to a combination of factors tied to Kimberly-Clark’s proposed acquisition of Kenvue and the stock’s recent pullback. He views KMB as a strategic acquirer of Kenvue’s assets, emphasizing that the categories are complementary and that the purchase price and EBITDA multiple look attractive relative to where Kenvue traded before Tylenol-related headline pressure.</p>
<div class="lb-trans"><p>安娜·利祖尔给予买入评级是基于与金佰利拟收购 Kenvue 相关的一系列因素，以及该股票近期的回调。她认为金佰利是 Kenvue 资产的战略收购者，强调这些类别是互补的，并且收购价格和 EBITDA 倍数相对于 Kenvue 在与泰诺相关的压力之前的交易情况看起来很有吸引力。</p>
</div><p>He also highlights the sizable potential for value creation from the combined company’s scale, projected revenue and EBITDA base, and planned cost and revenue synergies, especially if sector valuation multiples recover after a difficult start to 2026. In addition, he notes that some of Kenvue’s higher-growth, higher-margin brands—particularly in self care—could enhance KMB’s portfolio over time, while perceived legal overhangs on Tylenol appear to be easing, supporting his unchanged $120 price target and Buy stance.</p>
<div class="lb-trans"><p>她还强调了合并公司规模、预计收入和 EBITDA 基础以及计划中的成本和收入协同效应所带来的巨大价值创造潜力，特别是在 2026 年初经历困难后，如果行业估值倍数恢复。此外，她指出 Kenvue 的一些高增长、高利润品牌——特别是在自我护理领域——可能会随着时间的推移增强金佰利的投资组合，而对泰诺的法律风险的认知似乎正在减轻，这支持了她不变的 120 美元目标价和买入立场。</p>
</div><p>Lizzul covers the Consumer Defensive sector, focusing on stocks such as Clorox, Kimberly Clark, and Coty. According to TipRanks, Lizzul has an average return of -2.5% and a 38.79% success rate on recommended stocks.</p>
<div class="lb-trans"><p>利祖尔覆盖消费防御行业，关注如 Clorox、金佰利和 Coty 等股票。根据 TipRanks 的数据，利祖尔推荐股票的平均回报为-2.5%，成功率为 38.79%。</p>
</div><p>In another report released on April 29, RBC Capital also reiterated a Buy rating on the stock with a $162.00 price target.</p>
<div class="lb-trans"><p>在 4 月 29 日发布的另一份报告中，RBC 资本也重申了对该股票的买入评级，目标价为 162.00 美元。</p>
</div>

Buy Rating Reiterated on Kimberly-Clark as Strategic Kenvue Deal and Synergy Upside Support Unchanged $120 Price Target

Tip Ranks

Kimberly Clark

Kenvue

美国银行

高乐氏

科蒂

加拿大皇家银行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

重申对 Kimberly Clark 的买入评级，战略性 Kenvue 交易和协同效应的上行支持使目标价维持在 120 美元不变